The company was founded in 1997 by Dr Graham March, a pharmacist with substantial experience of the formulation of medicines gained whilst working at major pharmaceutical companies and within the UK’s National Health Service.
Dr March spent several years formulating medicines at Great Ormond Street Hospital, the world-renowned children’s hospital in London. Whilst working at the hospital, Dr March identified the need for a private sector company dedicated to developing medicines for children with rare diseases and for other patient groups.
Dr March, along with a small team of formulation experts at Veriton Pharma, has since developed more than 60 “specials” for a targeted range of therapeutic areas.
In general, liquids have been produced for children and tablets for older children and adults. Injections have also been manufactured to treat patients requiring emergency treatment. The company has grown rapidly, supplying products to more than 25 countries.
Licensed Products
We are committed to developing licensed medicinal products that meet the specific needs of our patients. Veriton Pharma’s portfolio of prescription medicines stems from our team’s deep expertise in the field of epilepsy.
News
- SAPHNA Annual Conference 2019: HEALTH FOR ALL CHILDREN
SAPHNA Annual Conference 2019: 18th June in Manchester We are delighted to be attending the upcoming SAPHNA Annual Conference; HEALTH FOR ALL CHILDREN – School and Public Health Nurses Turning the Tide…. Read More
- Young Epilepsy online guide for school
Veriton Pharma is pleased to announce the online publication of the charity Young Epilepsy’s online guide for schools. This comprehensive resource aimed at improving the management and support of children with epilepsy… Read More
- Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign
Young Epilepsy and Veriton Pharma Ltd (Veriton) have announced a key agreement, where the organisations will work in partnership to deliver the ‘Rules 4 Schools” element of the charity’s newly… Read More
- Epistatus® 10 Mg (In 1 Ml) Oromucosal Solution Midazolam Available on Nhs Prescription Is Approved For Use By Both the Scottish Medicines Consortium (Smc) and the All Wales Medicines Strategy Group (Awmsg)
Epistatus is licensed for use in the treatment of prolonged, acute convulsive seizures in children and adolescents aged 10 to less than 18 years, who have been diagnosed with epilepsy1. Epistatus… Read More